I like most everyone here, am certainly interested

I like most everyone here, am certainly interested and even anxious about the call today. I'm hopeful it is indeed to release some data, and given the new loan and the time that has passed since unblinding I am guardedly expecting there will be some concrete hard data. I may be wrong, but it sure seems like many other "competitors" have released "news" about their great results or preliminary data, and up they go. It seemed like GILD did that with Remdesivir, and I'm still not positive they ever released their full study results...Anybody? I did notice a little Canadian firm, Edesa (EDSA) announced that they were going to APPLY for FDA approval of a preliminary study for their MAB that " inhibits toll-like receptor 4 (TLR4) signaling - an important mediator of inflammation responsible for acute lung injury that has been shown to be activated by SARS-CoV1 and Influenza viruses." It had already tripled recently from 2 to $6 on Canadian approval of a trial, and just jumped from $5 to $20 this morning. Certainly backed off, but...I'm not a doctor or immunologist, but that seems to be another one that's using lighter fluid rather than charcoal to try and cook their burger (Dr P needs another shirt for that one!), and Leronlimab must blow that one away also. Therefore, I am looking for continued strength all day and very good news this afternoon and a BIG JUMP tomorrow. And with everything else going on with our little comapny, from their it's
To The Moon Alice